Ninni E. Olafsen
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Aryl hydrocarbon receptor pharmacology-mechanisms, ligands, and therapeutic potential.
Journal: Pharmacological reviews
Published: January 28, 2026
PARP7 and aryl hydrocarbon receptor differentially regulate mammary cancer cell proliferation and STING-induced type I interferon signalling.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: June 17, 2025
Loss of aryl hydrocarbon receptor reduces pancreatic tumor growth by increasing immune cell infiltration.
Journal: Biochemical pharmacology
Published: December 04, 2024
Corrigendum: Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells.
Journal: Frontiers in oncology
Published: October 24, 2024
Loss of Parp7 increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltration.
Journal: Frontiers in immunology
Published: October 18, 2024
Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells.
Journal: Frontiers in oncology
Published: July 18, 2024
Discovery and optimisation of pyrazolo[1,5-a]pyrimidines as aryl hydrocarbon receptor antagonists.
Journal: RSC medicinal chemistry
Published: April 17, 2024
Loss of PARP7 Increases Type I Interferon Signaling in EO771 Breast Cancer Cells and Prevents Mammary Tumor Growth by Increasing Antitumor Immunity.
Journal: Cancers
Published: May 24, 2023
Structurally distinct PARP7 inhibitors provide new insights into the function of PARP7 in regulating nucleic acid-sensing and IFN-β signaling.
Journal: Cell chemical biology
Published: April 16, 2022
Analysis of the effects of aryl hydrocarbon receptor expression on cancer cell invasion via three-dimensional microfluidic invasion assays.
Journal: Lab on a chip
Published: December 14, 2021
2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)-Inducible Poly-ADP-Ribose Polymerase (TIPARP/PARP7) Catalytic Mutant Mice (TiparpH532A) Exhibit Increased Sensitivity to TCDD-Induced Hepatotoxicity and Lethality.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: June 15, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026